Could a cheap gout pill soothe radiation burns?
NCT ID NCT05335148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether a low dose of colchicine, a medicine usually used for gout, can safely reduce skin redness and pain caused by radiation therapy in people with head and neck cancer. About 30 participants take one pill daily during their radiation treatment. The goal is to see if this approach can ease a common side effect that currently has no approved treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RWJBarnabas Health - Cooperman Barnabas
Livingston, New Jersey, 07039, United States
-
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08901, United States
-
Rutgers, The State University of New Jersey Board Contact:
New Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can targeted radiation boost Immunotherapy's power against head and neck cancer?
- Could a simple mouthwash protect cancer patients from Radiation's painful side effects?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Can a scan tell who needs more surgery after head and neck cancer?
- Can a new drug outperform standard care for head and neck cancer?